Back to immortality: The restoration of embryonic telomere length during induced pluripotency

Regenerative Medicine

Volumn 5, Issue 4, 2010, Pages 485-488

  West, Michael D ^a   Vaziri, Homayoun ^b  

^a BIOTIME INC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; TELOMERASE;

AGING; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; EDITORIAL; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GERM CELL; HUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGENERATIVE MEDICINE; RESTRICTION FRAGMENT; SOMATIC CELL; TELOMERE;

ANIMALS; CELL AGING; EMBRYO, MAMMALIAN; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TELOMERE;

EID: 77954784173     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.51     Document Type: Editorial

References (38)

1. Weismann A: Essays Upon Heredity and Kindred Biological Problems (Volume I). Clarendon Press, UK (1891).
2. McLaren A: Embryology: the quest for immortality. Nature 359, 482-483 (1992).
3. McLaren A: Mammalian germ cells: birth, sex, and immortality. Cell Struct. Funct. 26, 119-122 (2001).
4. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961).
5. Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636 (1965).
6. Hayflick L: Aging, longevity, and immortality in vitro. Exp. Gerontol. 27, 363-368 (1992).
7. Olovnikov AM: Principles of marginotomy in template synthesis of polynucleotides. Dokl. Akad. Nauk SSSR 201, 1496-1499 (1971).
8. Feng J, Funk WD, Wang S-S, et al.: The RNA component of human telomerase. Science 269, 1236-1241 (1995).
9. Nakamura TM, Morin GB, Chapman KB, et al.: Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959 (1997).
10. Bodnar AG, Ouellette M, Frolkis M, et al.: Extension of cell life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
11. Vaziri H, Benchimol S: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282 (1998).
12. West MD: Embryonic stem cells: prospects of regenerative medicine for the treatment of human aging. In: The Future of Aging. Fahy GM, West MD, Coles LS, Harris SB (Eds). Springer, New York, USA, 451-487 (2010) (In Press).
13. Shawi M, Autexier C: Telomerase, senescence, and ageing. Mech. Ageing Dev. 129, 3-10 (2008).
14. Shay JW, Wright WE: Use of telomerase to create bioengineered tissues. Ann. NY Acad. Sci. 1057, 479-491 (2005).
15. Huang Q, Chen M: Improving cell therapy: experiments using transplanted telomerase-immortalized cells in immunodeficient mice. Mech. Ageing Dev. 128 (1), 25-30 (2007).
16. Kim NW, Piatyszek MA, Prowse KR, et al.: Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2014 (1994).
17. Thomson JA, Itskovitx-Eldor J, Shapiro SS: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
18. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH: Viable offspring derived from fetal and adult mammalian cells. Nature 385(6619), 810-813 (1997).
19. Lanza RP, Cibelli JB, West MD: Prospects for the use of nuclear transfer in human transplantation. Nat. Biotechnol. 17(12), 1171-1174 (1999).
20. Lanza RP, Cibelli JB, West MD: Human therapeutic cloning. Nat. Med. 5(9), 975-977 (1999).
21. Shiels PG, Kind AJ, Campbell KH, et al.: Analysis of telomere lengths in cloned sheep. Nature 399(6734), 316-317 (1999).
22. Lanza RP, Cibelli JB, Blackwell C, et al.: Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science 288, 665-669 (2000).
23. Takahashi K, Tanabe K, Ohnuki M, et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
24. Yu J, Vodyanik MA, Smuga-Otto K, et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
25. Marion RM, Strati K, Li H, et al.: Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4(2), 141-154 (2009).
26. Suhr ST, Chang EA, Rodriguez RM, et al.: Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One 4(12), e8124 (2009).
27. Feng Q, Lu S-J, Klimanskaya I, et al.: Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion an early senescence. Stem Cells 28(4), 704-712 (2010).
28. Agarwal S, Loh YH, McLoughlin EM, et al.: Telomere elongation in induced pluripotent stem cells from dyskeratosis congenital patients. Nature 464(7286), 292-296 (2010).
29. Vaziri H, Chapman K, Guigova A, et al.: Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regen. Med. 5(3), 345-363 (2010).
30. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB: Telomere end-replication problem and cell aging. J. Mol. Biol. 225, 951-960 (1992).
31. Riethman H, Ambrosini A, Paul S: Human subtelomere structure and variation. Chrom. Res. 13(5), 505-515 (2005).
32. Chiu CP: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14, 239-248 (1996).
33. Allsopp RC: Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89, 10114-10118 (1992).
34. Binet R, Ythier D, Robles AI, et al.: WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 69(24), 9183-9191 (2009).
35. Hu BY, Weick JP, Yu J, et al.: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107(9), 4335-4340 (2010).
36. Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT: Telomere length changes after umbilical cord blood transplant. Transfusion 46(6), 1038-1043 (2006).
37. Schatteman GC, Ma N: Old bone marrow cells inhibit skin wound vascularization. Stem Cells 24(3), 717-721 (2006).
38. Le Douarin NM: Ontogeny of the peripheral nervous system from the neural crest and the placodes: a developmental model studied on the basis of the quail-chick chimaera system. Harvey Lect. 80, 137-186 (1984).